CARL SOLUTIONS
LIVE

Serial Number

79306697

Owner

ResuSciTec GmbH

Attorney

Alan E. Schiavelli

Filing Date

Nov 10, 2020

Add to watchlist:

No watchlists yet
View on USPTO

CARL SOLUTIONS Trademark

Serial Number: 79306697 • Registration: 6756309

CARL SOLUTIONS is a trademark filed by ResuSciTec GmbH on November 10, 2020. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 39 (Transportation & Storage), Class 41 (Education & Entertainment), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

ResuSciTec GmbH (17 trademarks)

Engesserstr. 4a

Entity Type: 16

Trademark Details

Filing Date

November 10, 2020

Registration Date

June 14, 2022

Published for Opposition

March 29, 2022

Goods & Services

Cardio training equipment for physical therapy purposes all designed specifically for medical use, namely, ergometers for medical testing purposes, bicycle ergometers for medical testing purposes, indoor cycles, treadmills, crosstrainers in the nature of ellipticals, rowing machine ergometers for medical purposes, stepper devices; physiotherapy and rehabilitation equipment all designed specifically for medical use, namely, shoulder stretcher using resistance cables, treadmills, stepper, and indoor bicycles; apparatus for the therapeutic stimulation of the muscles, including the heart muscle by applying electrodes on the chest, namely, electronic muscle stimulators for medical purposes; cardio training devices, namely, body rehabilitation apparatus for medical purposes

Training for handling scientific instruments and apparatus for research in laboratories; education services, namely, providing courses of instruction in the field of therapeutic treatments, namely, instruction in a method of treatment of people suffering cardiac arrest, by withdrawing blood from the patient, analyzing and modifying the blood and introducing the modified blood and/or a chosen substance into the patient body before starting conventional measures of resuscitation, such as heart rhythm massage and/or defibrillation, if necessary; training services in the field of health and safety, namely, instruction in a method of treatment of people suffering cardiac arrest, by withdrawing blood from the patient, analyzing and modifying the blood and introducing the modified blood and/or a chosen substance into the patient body before starting conventional measures of resuscitation, such as heart rhythm massage and/or defibrillation, if necessary; training services in the field of occupational health, namely, instruction in a method of treatment of people suffering cardiac arrest, by withdrawing blood from the patient, analyzing and modifying the blood and introducing the modified blood and/or a chosen substance into the patient body before starting conventional measures of resuscitation, such as heart rhythm massage and/or defibrillation, if necessary; medical education services in the nature of courses of instruction in the field of treatment of people suffering cardiac arrest, by withdrawing blood from the patient, analyzing and modifying the blood and introducing the modified blood and/or a chosen substance into the patient body before starting conventional measures of resuscitation, such as heart rhythm massage and/or defibrillation, if necessary; educational services in the nature of courses of instruction in the field of first aid, namely, instruction in a method of treatment of people suffering cardiac arrest, by withdrawing blood from the patient, analyzing and modifying the blood and introducing the modified blood and/or a chosen substance into the patient body before starting conventional measures of resuscitation, such as heart rhythm massage and/or defibrillation, if necessary; training services for medical visitors in the field of treatment of people suffering cardiac arrest, by withdrawing blood from the patient, analyzing and modifying the blood and introducing the modified blood and/or a chosen substance into the patient body before starting conventional measures of resuscitation, such as heart rhythm massage and/or defibrillation, if necessary; teaching services in the nature of courses of instruction in the surgical field, namely, instruction in a method of treatment of people suffering cardiac arrest, by withdrawing blood from the patient, analyzing and modifying the blood and introducing the modified blood and/or a chosen substance into the patient body before starting conventional measures of resuscitation, such as heart rhythm massage and/or defibrillation, if necessary; education services in the nature of courses of instruction in the field of medicine, namely, instruction in a method of treatment of people suffering cardiac arrest, by withdrawing blood from the patient, analyzing and modifying the blood and introducing the modified blood and/or a chosen substance into the patient body before starting conventional measures of resuscitation, such as heart rhythm massage and/or defibrillation, if necessary; training services in the field of first aid, namely, instruction in a method of treatment of people suffering cardiac arrest, by withdrawing blood from the patient, analyzing and modifying the blood and introducing the modified blood and/or a chosen substance into the patient body before starting conventional measures of resuscitation, such as heart rhythm massage and/or defibrillation, if necessary; workshops for educational purposes in the field of treatment of people suffering cardiac arrest, by withdrawing blood from the patient, analyzing and modifying the blood and introducing the modified blood and/or a chosen substance into the patient body before starting conventional measures of resuscitation, such as heart rhythm massage and/or defibrillation, if necessary

Measuring, detecting and monitoring instruments, indicators and controllers for measuring, detecting, and monitoring electrical, physiological and chemical properties of biological organism, including a human or an animal for scientific research uses, namely, for measuring, detecting, and monitoring electrical, physiological and chemical properties of people suffering cardiac arrest, and from whom blood has been withdrawn, analyzed and modified, and into whom the modified blood and/or a chosen substance is introduced before starting conventional measures of resuscitation, such as heart rhythm massage and/or defibrillation, if necessary; automatic dosage apparatus, namely, machines for dispensing pre-determined dosages of medication, in particular, medical drugs, and blood or blood substitute for influencing physiological and chemical blood properties; electronic indicator panels for indicating body activity and function of a human or an animal not for medical purposes; electric monitoring units for monitoring body activities of a human or an animal for scientific research uses, namely, for monitoring body activities of people suffering cardiac arrest, and from whom blood has been withdrawn, analyzed and modified, and into whom the modified blood and/or a chosen substance is introduced before starting conventional measures of resuscitation, such as heart rhythm massage and/or defibrillation, if necessary; electric monitoring control apparatus for monitoring and controlling body activity and function of a human or an animal, including cardiac activity for scientific research uses, namely, for and controlling cardiac activity, and body activity and function of people suffering cardiac arrest, and from whom blood has been withdrawn, analyzed and modified, and into whom the modified blood and/or a chosen substance is introduced before starting conventional measures of resuscitation, such as heart rhythm massage and/or defibrillation, if necessary; all the aforesaid goods in this class excluding the use thereof in the field of maintenance management and financial management

Rescue of people; rescue services

Medical and veterinary preparations and articles, namely, for treatment of heart reduced output, cardiac arrhythmias, cardiac arrest, and stroke, and for resuscitation; pharmaceuticals and natural remedies for the treatment of heart reduced output, cardiac arrhythmias, cardiac arrest, and stroke, and for the purpose of resuscitation; diagnostic preparations for medical and veterinary use for detecting physiological and blood-specific properties of a human or an animal; medical dressings, medical coverings and medical applicators for cover and reseal of wounds and applicators prefilled with medical drugs for treatment of heart reduced output, cardiac arrhythmias, cardiac arrest, and stroke, in particular for resuscitation and or blood for medical use for treatment of heart reduced output, cardiac arrhythmias, cardiac arrest, and stroke, in particular for resuscitation or blood substitute for medical use for treatment of heart reduced output, cardiac arrhythmias, cardiac arrest, and stroke, in particular for resuscitation; medicines for veterinary purposes for the treatment of heart reduced output, cardiac arrhythmias, cardiac arrest, and stroke, and resuscitation; biological preparations for medical purposes for the treatment of heart reduced output, cardiac arrhythmias, cardiac arrest, and stroke, and for resuscitation; biological preparations for veterinary and medical purposes for the treatment of heart reduced output, cardiac arrhythmias, cardiac arrest, and stroke, and for resuscitation; blood for medical purposes; blood components for medical purposes for treatment of heart reduced output, cardiac arrhythmias, cardiac arrest, and stroke, and for resuscitation; blood substitutes for medical and veterinary use for treatment of heart reduced output, cardiac arrhythmias, cardiac arrest, and stroke, and for resuscitation; blood plasma; enzymes for veterinary purposes; enzyme preparations for medical purposes; enzyme preparations for veterinary purposes; solid oxygen for medical use; gases for medical purposes; gas mixtures for medical use; haemoglobin; cooling sprays for medical purposes; pharmaceutical preparations for veterinary use for the treatment of heart reduced output, cardiac arrhythmias, cardiac arrest, and stroke, and for resuscitation; radioactive substances for medical purposes; solidified gases for medical purposes; veterinary preparations for the treatment of heart reduced output, cardiac arrhythmias, cardiac arrest, and stroke, and for resuscitation

Ambulant medical care, namely, treatment of people suffering cardiac arrest, by withdrawing blood from the patient, analyzing and modifying the blood and introducing the modified blood and/or a chosen substance into the patient body before starting conventional measures of resuscitation, such as heart rhythm massage and/or defibrillation, if necessary; physician services, namely, treatment of people suffering cardiac arrest, by withdrawing blood from the patient, analyzing and modifying the blood and introducing the modified blood and/or a chosen substance into the patient body before starting conventional measures of resuscitation, such as heart rhythm massage and/or defibrillation, if necessary; medical care, namely, treatment of people suffering cardiac arrest, by withdrawing blood from the patient, analyzing and modifying the blood and introducing the modified blood and/or a chosen substance into the patient body before starting conventional measures of resuscitation, such as heart rhythm massage and/or defibrillation, if necessary; services for the provision of medical care information, namely, providing information concerning treatment of people suffering cardiac arrest by withdrawing blood from the patient, analyzing and modifying the blood and introducing the modified blood and/or a chosen substance into the patient body before starting conventional measures of resuscitation, such as heart rhythm massage and/or defibrillation, if necessary; medical analysis of human tissues for medical treatment; therapeutic treatment of the body in the nature of medical treatment of people suffering cardiac arrest, by withdrawing blood from the patient, analyzing and modifying the blood and introducing the modified blood and/or a chosen substance into the patient body before starting conventional measures of resuscitation, such as heart rhythm massage and/or defibrillation, if necessary; telemedicine services; Providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals used in the treatment of people suffering cardiac arrest, as part of a regimen that includes withdrawing blood from the patient, analyzing and modifying the blood with pharmaceuticals and introducing the modified blood and/or a chosen pharmaceutical substance into the patient body before starting conventional measures of resuscitation, such as heart rhythm massage and/or defibrillation, if necessary; medical and pharmaceutical consultation; physical therapy; emergency medical assistance, namely, treatment of people suffering cardiac arrest, by withdrawing blood from the patient, analyzing and modifying the blood and introducing the modified blood and/or a chosen substance into the patient body before starting conventional measures of resuscitation, such as heart rhythm massage and/or defibrillation, if necessary; medical assistance, namely, treatment of people suffering cardiac arrest, by withdrawing blood from the patient, analyzing and modifying the blood and introducing the modified blood and/or a chosen substance into the patient body before starting conventional measures of resuscitation, such as heart rhythm massage and/or defibrillation, if necessary; medical services, namely, treatment of people suffering cardiac arrest, by withdrawing blood from the patient, analyzing and modifying the blood and introducing the modified blood and/or a chosen substance into the patient body before starting conventional measures of resuscitation, such as heart rhythm massage and/or defibrillation, if necessary; medical services for the diagnosis of conditions of the human body, namely, withdrawing blood from the patient, analyzing and modifying the blood and introducing the modified blood and/or a chosen substance into the patient body before starting conventional measures of resuscitation, such as heart rhythm massage and/or defibrillation, if necessary; medical services for the treatment of conditions of the human body, namely, treatment of people suffering cardiac arrest, by withdrawing blood from the patient, analyzing and modifying the blood and introducing the modified blood and/or a chosen substance into the patient body before starting conventional measures of resuscitation, such as heart rhythm massage and/or defibrillation, if necessary; medical evaluation services, namely, analyzing and modifying the blood and introducing the modified blood and/or a chosen substance into the patient body before starting conventional measures of resuscitation, such as heart rhythm massage and/or defibrillation, if necessary; medical advisory services, namely, providing medical advice regarding treatment of people suffering cardiac arrest, by withdrawing blood from the patient, analyzing the blood before starting conventional measures of resuscitation, such as heart rhythm massage and/or defibrillation, if necessary; medical treatment services, namely, treatment of people suffering cardiac arrest, by withdrawing blood from the patient, analyzing and modifying the blood and introducing the modified blood and/or a chosen substance into the patient body before starting conventional measures of resuscitation, such as heart rhythm massage and/or defibrillation, if necessary; physical rehabilitation; medical health assessment services; medical testing services, namely, medical testing of blood for purposes of introducing the modified blood and/or a chosen substance into the patient body before starting conventional measures of resuscitation, such as heart rhythm massage and/or defibrillation, if necessary; medical clinic services, namely, treatment of people suffering cardiac arrest, by withdrawing blood from the patient, analyzing and modifying the blood and introducing the modified blood and/or a chosen substance into the patient body before starting conventional measures of resuscitation, such as heart rhythm massage and/or defibrillation, if necessary; surgery, namely, treatment of people suffering cardiac arrest, by surgically withdrawing blood from the patient, analyzing and modifying the blood and introducing the modified blood and/or a chosen substance into the patient body before starting conventional measures of resuscitation, such as heart rhythm massage and/or defibrillation, if necessary

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Oct 17, 2022 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Sep 23, 2022 FICS
FINAL DISPOSITION PROCESSED
Sep 23, 2022 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Sep 14, 2022 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jun 14, 2022 NRCC
REGISTERED-PRINCIPAL REGISTER
Jun 14, 2022 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 29, 2022 NPUB
PUBLISHED FOR OPPOSITION
Mar 29, 2022 PUBO
NOTIFICATION PROCESSED BY IB
Mar 27, 2022 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Mar 9, 2022 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Mar 9, 2022 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 9, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 22, 2022 CNSA
EXAMINER'S AMENDMENT ENTERED
Feb 22, 2022 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Feb 22, 2022 GNEN
EXAMINERS AMENDMENT E-MAILED
Feb 22, 2022 GNEA
EXAMINERS AMENDMENT -WRITTEN
Feb 22, 2022 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 12, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 11, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 11, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 12, 2021 GNRN
NON-FINAL ACTION E-MAILED
Jul 12, 2021 GNRT
NON-FINAL ACTION WRITTEN
Jul 12, 2021 CNRT
LIMITATION FROM THE IB - REQUEST EXAM REVIEW
Jun 29, 2021 LIME
LIMITATION OF GOODS RECEIVED FROM IB
Jun 19, 2021 LIMG
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 5, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 4, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 4, 2021 TROA
REFUSAL PROCESSED BY IB
May 24, 2021 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Apr 27, 2021 RFCS
REFUSAL PROCESSED BY MPU
Apr 27, 2021 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Apr 23, 2021 RFCR
NON-FINAL ACTION WRITTEN
Apr 22, 2021 CNRT
ASSIGNED TO EXAMINER
Apr 20, 2021 DOCK
APPLICATION FILING RECEIPT MAILED
Mar 23, 2021 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 19, 2021 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Mar 18, 2021 REPR